Similarly, ASA treatments inhibited the survival of human PAF-R-negative SK5MEL melanoma and PAF-R-positive KBP and negative KBM nasopharyngeal carcinoma cells (Supplementary Figure 2A-2F) generated via retroviral-mediated transduction as reported by us [18–19, 52]. The gene discussed is PTAFR; the disease is melanoma.